January 2022

3 Minutes
TechNews-PR Newswire

Insilico Medicine Announces the Nomination of Two Preclinical Candidates for PHD2, 12 Months After Program Initiation

NEW YORK and SHANGHAI, Jan. 5, 2022 /PRNewswire/ — Insilico Medicine, a global clinical-stage biotechnology company specializing in the applications of end-to-end artificial intelligence (AI) for drug discovery and development, today announced that the company...
Read More